Monkey IL-4 T cell ELISPOT kit - 5-plate

SKU
CT128-B5
Complete ELISPOT kit including all reagents (480 determinations).
Species reactivity: rhesus macaque, cynomolgus monkey, pig-tailed macaque, Japanese macaque, crested black macaque, barbary macaque, lion-tailed macaque, baboon, mandrill, black mangabey and hanuman langur.
Format
5-plate
Price
€ 670
Reactivity
Monkey
Category
T cell ELISPOT
Analyte
IL-4
Description
Our ELISPOT kits provide a complete, ready-to-use solution for reliable, high-performance ELISPOT assay. Each kit includes all essential components: coating and detection antibodies, streptavidin-HRP, TMB substrate, blocking stock solution, dilution buffer, and Tween-20.
Description
Interleukin-4 (IL-4) is a key cytokine that plays a central role in regulating the immune system. It is primarily produced by T helper 2 (Th2) cells, but can also be secreted by mast cells, and eosinophils and basophils. IL-4 is involved in several critical immune processes, including IgE class switching in B cell, Th2 cell differentiation, allergic inflammation and defense against parasites.
Alternative names
IL-4, Interleukin 4, Interleukin-4, IL4, BCGF-1, BGF1, BSF-1, BSF1, IL4E12
Image
Image

References

Authors, et al. Title Journal Year Volume Pages
Juan Liu Immunogenicity and protective efficacy of the HC009 mRNA vaccine against SARS-CoV-2 Front Immunol 2024 15 1416375
Yaling An A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates Emerg Microbes Infect 2022 11 1058-1071
Liang Qu Circular RNA vaccines against SARS-CoV-2 and emerging variants Cell 2022 185 1728-1744.e16
Petra Mooij Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2 Front Immunol 2022 13 845887
Ariane Volkmann A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques Front Immunol 2022 13 857440
Stefania Capone Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19 Mol Ther 2021 29 2412-2423
Xiancai Ma Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses Immunity 2020 53 1315-1330.e9
C Rollier T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates Gene Ther 2016 23 753-759
Willy Bogers Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion J Infect Dis 2015 211 947-55
Souvik Karmakar Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons J Infect Dis 2014 209 1929-40